Abstract
Bayer and Ginkgo Bioworks are forming a company to exploit the potential of synthetic biology to improve microbes that help plants grow. The as yet unnamed firm launches with a $100 million investment from the parent companies and Viking Global Investors. Plants such as soybeans, peas, and peanuts benefit from symbiotic microbes that fix nitrogen from the air and make it available to plant roots. The new company seeks to boost the abilities of these microbes. It will be based at Gingko’s Boston labs and the West Sacramento, Calif., home of Bayer’s plant biologic activities.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
